6 results about "Temozolomide" patented technology

This invention provides a combination for use in treating cancers that express prostate-specific membrane antigen (PSMA). [Solution] A combination comprising a PD-1 inhibitor, a CTLA-4 inhibitor, and a radiolabeled compound of formula Ia for use in treating PSMA-expressing cancer in the subject. JPEG2026049728000042.jpg45132 The aforementioned combination comprises one or more further anticancer agents, wherein the further anticancer agents are selected from octreotide, lanreotide, vapreotide, pasireotide, satreotide, everolimus, temozolomide, telotristat, sunitinib, sulfatinib, ribociclib, entinostat, and pazopanib.

The application discloses application of a swertianol derivative in preparation of a glioma treatment drug and belongs to the technical field of medicines. The application finds that the compound has significant inhibitory activity on SF126, T98G, A172, U-87 MG, U251 and various glioma cell lines, and the activity is better than that of temozolomide, a commonly used clinical anti-glioma drug, and the compound has lower toxicity to normal brain cells. The application further provides a preparation method of the compound and a pharmaceutical composition containing the compound, and the pharmaceutical composition can be prepared into injection, tablets and various dosage forms. The application provides a new effective drug selection for the treatment of glioma, has a mature preparation process, various drug dosage forms and a wide clinical application prospect.

The invention discloses application of carabrone derivatives in preparation of glioma drugs, and belongs to the technical field of medicines. It is found for the first time that the compound has remarkable inhibitory activity on multiple glioma cell lines such as SF126, T98G, A172, U-87 MG and U251, the activity of the compound is superior to that of temozolomide which is a clinically common anti-glioma drug, and meanwhile the compound is low in toxicity to normal brain cells. The invention also provides a preparation method of the compound and a pharmaceutical composition containing the compound. The pharmaceutical composition can be prepared into various dosage forms such as injections, tablets and the like. The invention provides a new effective drug choice for the treatment of glioma, and has the advantages of mature preparation process, various dosage forms and wide clinical application prospect.

The application discloses a targeted drug for treating glioma and a preparation method and application thereof. Alkaline copper carbonate, dopamine hydrochloride and ammonia water are mixed and dissolved, then defatted cotton is added, stirring is conducted until the defatted cotton is dissolved, and copper ammonia fiber solution is obtained by reaction at room temperature; a mixed solution of soluble copper ion salt, zinc ion salt and cobalt ion salt is prepared as a metal ion acid bath solution; the copper ammonia fiber solution is slowly injected into the metal ion acid bath solution, stirring reaction is completed, and then centrifugal separation is conducted; the obtained precipitate is added into a temozolomide solution, ultrasonic treatment is conducted under ice bath, and then centrifugal separation is conducted to obtain a precipitate; the precipitate is washed and freeze-dried to obtain polydopamine modified temozolomide adsorbed copper ammonia fiber; finally, the obtained polydopamine modified temozolomide adsorbed copper ammonia fiber is added into phosphate buffer solution containing Anti-ATRX antibody for incubation, and then washing, freeze-drying and grinding are conducted to obtain the product.

Provided herein are methods of treating a cancer in a subject, and methods of improving responsiveness of a subject to a cancer therapy. Also provided herein is tigilanol tiglate and pharmaceutical compositions thereof for use in such methods, and uses of tigilanol tiglate and pharmaceutical compositions thereof for treating cancer and improving responsiveness to a subsequent cancer therapy, such as immune checkpoint inhibitors, gemcitabine, docetaxel, or temololomide.

The invention relates to the technical field of biology, and discloses a nano-composite and a preparation method and application thereof, the nano-composite is used for realizing diagnosis and treatment integration of glioblastoma, and the nano-composite comprises nanogel, nano-particles loaded with ultra-small Fe3O4, temozolomide and PD-L1siRNA. The preparation process of the nano material is relatively easy, and the USIO NGs-TMZ / siRNA compound is relatively stable in vivo, so that the loaded gene can be prevented from being degraded by enzyme in vivo in the transportation process, the siRNA is promoted to realize rapid endosome escape, and the tumor treatment effect is enhanced.